Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 62332-815

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 62332-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Diltiazem-120-mg-cap (Diltiazem 120 mg Cap)

Diltiazem-120-mg-cap (Diltiazem 120 mg Cap)
This text provides detailed information about Diltiazem Hydrochloride Extended-Release capsules containing 120 mg of the active ingredient. The storage conditions, manufacturer details, and dosage recommendations are clearly outlined. The product is manufactured by Alembic Pharmaceuticals Limited in Gujarat, India, and marketed by Alembic Pharmaceuticals, Inc. in the USA. The package includes 100 child-resistant capsules with expiration date 07/2024 and a unique identification code. It is advised to store the capsules in a tight, light-resistant container and at a controlled room temperature. Further dosage instructions can be found in the package insert.*
FDA Label Image

Diltiazem-180-mg-cap (Diltiazem 180 mg Cap)

Diltiazem-180-mg-cap (Diltiazem 180 mg Cap)
This is a description of Diltiazem Hydrochloride Extended-Release Capsules. Each capsule contains 180 mg of diltiazem hydrochloride, USP. The storage instructions indicate keeping the capsules at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The capsules should be dispensed in a tight, light-resistant container and kept tightly closed. The usual dosage information is available in the package insert. The manufacturing details mention that these capsules are manufactured by Alembic Pharmaceuticals Limited in Gujarat, India, and manufactured for Alembic Pharmaceuticals, Inc. in Bedminster, NJ, USA. It is a once-a-day dosage and the package contains 100 child-resistant capsules. The expiration date is 07/2024. This product has NDC 62332-816-31 and GTIN 00362332816316.*
FDA Label Image

Diltiazem-240-mg-cap (Diltiazem 240 mg Cap)

Diltiazem-240-mg-cap (Diltiazem 240 mg Cap)
This text provides information about Diltiazem Hydrochloride Extended-Release Capsules, USP. Each capsule contains 240 mg of diltiazem hydrochloride. The storage instructions recommend keeping the capsules at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15° to 30°C (59°F to 86°F). The capsules should be dispensed in a tight, light-resistant container. The manufacturer is Alembic Pharmaceuticals Limited, located in Gujarat, India, and the product is manufactured for Alembic Pharmaceuticals, Inc. in Bedminster, NJ, USA. The package is child-resistant and contains 100 capsules. The expiration date is 07/2024.*
FDA Label Image

Diltiazem-str.jpg (Diltiazem Str)

Diltiazem-str.jpg (Diltiazem Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.